Testing effectiveness (Phase 2)Ended earlyNCT00277316What this trial is testingStudy of XL999 in Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Symphony Evolution, Inc. 11
Not applicableStudy completedNCT01836406What this trial is testingEffect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial NephrectomyWho this might be right forRenal Cell Carcinoma Yonsei University 16
Post-approval studies (Phase 4)Study completedNCT02555748What this trial is testingTherapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Cancer Institut Claudius Regaud 47
Testing effectiveness (Phase 2)Study completedNCT00835978What this trial is testingAxitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney CancerWho this might be right forCarcinoma, Renal Cell Pfizer 213
Not applicableTemporarily pausedNCT04669860What this trial is testingEvaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell CarcinomaWho this might be right forCalcium Oxalate UrolithiasisRenal Cell Carcinoma University of Miami 90
Testing effectiveness (Phase 2)Study completedNCT01361113What this trial is testingNeoadjuvant Pazopanib in Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma UNC Lineberger Comprehensive Cancer Center 21
Not applicableActive Not RecruitingNCT01582204What this trial is testingEvaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cancer Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01064310What this trial is testingPatient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney CancerWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 169
Testing effectiveness (Phase 2)Study completedNCT00664326What this trial is testingA Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCCWho this might be right forCarcinoma, Renal Cell Bayer 49
Not applicableActive Not RecruitingNCT05863052What this trial is testingAnalyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationWho this might be right forImmune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more University of Oklahoma 72
Very early researchStudy completedNCT05728515What this trial is testingA Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 3
Not applicableEnded earlyNCT01598038What this trial is testingRelation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Centre Francois Baclesse 41
Testing effectiveness (Phase 2)Study completedNCT00019955What this trial is testingRadiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)Who this might be right forKidney Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03015740What this trial is testingSitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00021021What this trial is testingRPI.4610 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Ribozyome
Not applicableStudy completedNCT07436416What this trial is testingCirculating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney CancerWho this might be right forRenal Cell Carcinoma Institute of Oncology Ljubljana 91
Not applicableStudy completedNCT04402749What this trial is testingThe Incidence of Pulmonary Embolism During NephrectomyWho this might be right forPulmonary EmbolismRenal Cell CarcinomaNephrectomy Mahidol University 416
Early research (Phase 1)Study completedNCT03063762What this trial is testingStudy to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776717What this trial is testingTACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT02697591What this trial is testingINCAGN01876 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 100